Arcus Biosciences stockRCUS
Arcus Biosciences trades at $17.69, 44.3% below its 52-week high (Jun 30, 2026). The price is below its 50- and 200-day averages, a downtrend. −25.8% year to date, −10.4% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 10, 2026.
Ratings, candles, signals and the screener for RCUS — after you log in
Open the terminalFrequently asked questions about Arcus Biosciences
What is the Arcus Biosciences stock price?
At the close on Nov 5, 2026: $17.69 (−8.39% on the day). 52-week high: $31.73 on Jun 30, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Arcus Biosciences report earnings?
The next quarterly report is on Nov 10, 2026. Last quarter, earnings per share changed −14,794% year over year, revenue −74%.
Does Arcus Biosciences pay dividends?
No, Arcus Biosciences does not pay dividends.
Where does Arcus Biosciences trade and how to buy it?
Ticker RCUS, exchange NYSE, listed since 2018. You can buy it through a broker with access to US exchanges.
Should I buy Arcus Biosciences now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for RCUS are in the terminal after you log in.